| How the interval between prime and boost injection affects the immune response in a computational model of the immune system F Castiglione, F Mantile, P De Berardinis, A Prisco Computational and mathematical methods in medicine 2012, 2012 | 170 | 2012 |
| Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy M Delfi, R Sartorius, M Ashrafizadeh, E Sharifi, Y Zhang, P De Berardinis, ... Nano Today 38, 101119, 2021 | 154 | 2021 |
| Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses P De Berardinis, R Sartorius, C Fanutti, RN Perham, G Del Pozzo, ... Nature biotechnology 18 (8), 873-876, 2000 | 122 | 2000 |
| Viral emerging diseases: challenges in developing vaccination strategies M Trovato, R Sartorius, L D’Apice, R Manco, P De Berardinis Frontiers in immunology 11, 570590, 2020 | 104 | 2020 |
| Interleukin 7 is a growth factor for mature human T cells M Londei, A Verhoef, C Hawrylowicz, J Groves, P de Berardinis, ... European journal of immunology 20 (2), 425-428, 1990 | 93 | 1990 |
| Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments M Gaubin, C Fanutti, Z Mishal, A Durrbach, P De Berardinis, R Sartorius, ... DNA and cell biology 22 (1), 11-18, 2003 | 83 | 2003 |
| Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21 V Costa, C Angelini, L D'Apice, M Mutarelli, A Casamassimi, L Sommese, ... PloS one 6 (4), e18493, 2011 | 82 | 2011 |
| Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-γ and interleukin-4 R Troncone, C Gianfrani, G Mazzarella, L Greco, J Guardiola, S Auricchio, ... Digestive diseases and sciences 43, 156-161, 1998 | 80 | 1998 |
| Filamentous bacteriophage fd as an antigen delivery system in vaccination A Prisco, P De Berardinis International journal of molecular sciences 13 (4), 5179-5194, 2012 | 71 | 2012 |
| Do CD4-positive cytotoxic T cells damage islet β cells in type 1 diabetes? P De Berardinis, RFL James, PH Wise, M Londei, SP Lake, M Feldmann The Lancet 332 (8615), 823-824, 1988 | 71 | 1988 |
| The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses R Sartorius, P Pisu, L D’Apice, L Pizzella, C Romano, G Cortese, ... The Journal of Immunology 180 (6), 3719-3728, 2008 | 69 | 2008 |
| Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines R Sartorius, M Trovato, R Manco, L D’Apice, P De Berardinis npj Vaccines 6 (1), 127, 2021 | 68 | 2021 |
| Definition of a population of CD4-8-T cells that express the alpha beta T-cell receptor and respond to interleukins 2, 3, and 4. M Londei, A Verhoef, P De Berardinis, M Kissonerghis, ... Proceedings of the National Academy of Sciences 86 (21), 8502-8506, 1989 | 67 | 1989 |
| Vaccination with filamentous bacteriophages targeting DEC‐205 induces DC maturation and potent anti‐tumor T‐cell responses in the absence of adjuvants R Sartorius, C Bettua, L D'Apice, A Caivano, M Trovato, D Russo, I Zanoni, ... European journal of immunology 41 (9), 2573-2584, 2011 | 63 | 2011 |
| Novel antigen delivery systems M Trovato, P De Berardinis World journal of virology 4 (3), 156, 2015 | 60 | 2015 |
| Efficient Propagation and Cloning of Human T Cells in the Absence of Antigen by Means of OKT3, Interleukin 2, and Antigen‐Presenting Cells M Londei, B Grubeck‐Loebenstein, P De Berardinis, C Greenall, ... Scandinavian journal of immunology 27 (1), 35-46, 1988 | 57 | 1988 |
| HIV vaccination: a roadmap among advancements and concerns M Trovato, L D’Apice, A Prisco, P De Berardinis International journal of molecular sciences 19 (4), 1241, 2018 | 55 | 2018 |
| Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages P De Berardinis, L D'Apice, A Prisco, MN Ombra, P Barba, G Del Pozzo, ... Vaccine 17 (11-12), 1434-1441, 1999 | 49 | 1999 |
| The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. P De Berardinis, M Londei, M Kahan, F Balsano, S Kontiainen, EA Gale, ... Clinical and experimental immunology 73 (2), 255, 1988 | 47 | 1988 |
| Antigen delivery by filamentous bacteriophage fd displaying an anti‐DEC‐205 single‐chain variable fragment confers adjuvanticity by triggering a TLR 9‐mediated immune response R Sartorius, L D'Apice, M Trovato, F Cuccaro, V Costa, MG De Leo, ... EMBO molecular medicine 7 (7), 973-988, 2015 | 43 | 2015 |
